Table 3. Meta-analysis of rs2254546 in association with KD risk stratified by study design.

	Case-control		TDT		OR (95%CI)
Study ID	Cases G/A	Controls G/A	Transmitted G	Non-transmitted G	Case-control	TDT
Onouchi (GWAS), 2012	702/154	4866/1892	-	-	1.77 (1.48–2.13)	-
Onouchi (CC1), 2012	761/179	522/234	-	-	1.91 (1.52–2.38)	-
Onouchi (CC2), 2012	454/114	808/330	-	-	1.63 (1.28–2.07)	-
Onouchi (TDT1), 2012	-	-	75	60	-	1.25 (0.89–1.76)
Onouchi (TDT2), 2012	-	-	24	16	-	1.50 (0.80–2.82)
Onouchi (TDT3), 2012	-	-	21	12	-	1.75 (0.86–3.56)
Onouchi (TDT4), 2012	-	-	25	19	-	1.32 (0.72–2.39)
Yan, 2013	590/126	1246/384	-	-	1.44 (1.15–1.81)	-
Current study, 2013	664/172	724/224	-	-	1.19 (0.95–1.50)	-
Pooled	3171/745	8166/3064	145	107	1.57 (1.34–1.85)†	1.35 (1.05–1.74)‡

^†Random-effects pooled OR, P < 0.001; Q = 10.84, P_{heterogeneity} = 0.028.

^‡Fixed-effects pooled OR, P = 0.018; Q = 0.83, P_{heterogeneity} = 0.843.